Speculation on why Steven Haffner tipped off GSK on the NEJM’s damning Avandia study.
Related Stories
More in Uncategorized
Comments
Previous post: Changing the pre-clinical curriculum
Next post: Pain wars
Speculation on why Steven Haffner tipped off GSK on the NEJM’s damning Avandia study.
Previous post: Changing the pre-clinical curriculum
Next post: Pain wars
